311 related articles for article (PubMed ID: 16713332)
41. Tuberous sclerosis complex and epilepsy: recent developments and future challenges.
Holmes GL; Stafstrom CE;
Epilepsia; 2007 Apr; 48(4):617-30. PubMed ID: 17386056
[TBL] [Abstract][Full Text] [Related]
42. Sacrococcygeal chordomas in patients with tuberous sclerosis complex show somatic loss of TSC1 or TSC2.
Lee-Jones L; Aligianis I; Davies PA; Puga A; Farndon PA; Stemmer-Rachamimov A; Ramesh V; Sampson JR
Genes Chromosomes Cancer; 2004 Sep; 41(1):80-5. PubMed ID: 15236319
[TBL] [Abstract][Full Text] [Related]
43. Protein levels of alpha1-tubulin, protein disulfide isomerase, tropomyosins and vimentin are regulated by the tuberous sclerosis gene products.
Hengstschläger M; Rosner M; Fountoulakis M; Oh JE; Lubec G
Cancer Lett; 2004 Jul; 210(2):219-26. PubMed ID: 15183538
[TBL] [Abstract][Full Text] [Related]
44. Tuberous sclerosis complex: disease modifiers and treatments.
Au KS; Ward CH; Northrup H
Curr Opin Pediatr; 2008 Dec; 20(6):628-33. PubMed ID: 19005330
[TBL] [Abstract][Full Text] [Related]
45. Metastasis of benign tumor cells in tuberous sclerosis complex.
Henske EP
Genes Chromosomes Cancer; 2003 Dec; 38(4):376-81. PubMed ID: 14566858
[TBL] [Abstract][Full Text] [Related]
46. Tuberous sclerosis complex.
Islam MP; Roach ES
Handb Clin Neurol; 2015; 132():97-109. PubMed ID: 26564073
[TBL] [Abstract][Full Text] [Related]
47. Mutational analysis of the TSC1 and TSC2 genes in a diagnostic setting: genotype--phenotype correlations and comparison of diagnostic DNA techniques in Tuberous Sclerosis Complex.
Sancak O; Nellist M; Goedbloed M; Elfferich P; Wouters C; Maat-Kievit A; Zonnenberg B; Verhoef S; Halley D; van den Ouweland A
Eur J Hum Genet; 2005 Jun; 13(6):731-41. PubMed ID: 15798777
[TBL] [Abstract][Full Text] [Related]
48. Mutational spectrum of the TSC1 gene in a cohort of 225 tuberous sclerosis complex patients: no evidence for genotype-phenotype correlation.
van Slegtenhorst M; Verhoef S; Tempelaars A; Bakker L; Wang Q; Wessels M; Bakker R; Nellist M; Lindhout D; Halley D; van den Ouweland A
J Med Genet; 1999 Apr; 36(4):285-9. PubMed ID: 10227394
[TBL] [Abstract][Full Text] [Related]
49. Expression of tuberin and hamartin in tuberous sclerosis complex-associated and sporadic cortical dysplasia of Taylor's balloon cell type.
Grajkowska W; Kotulska K; Matyja E; Larysz-Brysz M; Mandera M; Roszkowski M; Domańska-Pakieła D; Lewik-Kowalik J; Jóźwiak S
Folia Neuropathol; 2008; 46(1):43-8. PubMed ID: 18368626
[TBL] [Abstract][Full Text] [Related]
50. Tuberous sclerosis gene products in proliferation control.
Hengstschläger M; Rodman DM; Miloloza A; Hengstschläger-Ottnad E; Rosner M; Kubista M
Mutat Res; 2001 Jul; 488(3):233-9. PubMed ID: 11397651
[TBL] [Abstract][Full Text] [Related]
51. Tuberin and hamartin are aberrantly expressed and linked to clinical outcome in human breast cancer: the role of promoter methylation of TSC genes.
Jiang WG; Sampson J; Martin TA; Lee-Jones L; Watkins G; Douglas-Jones A; Mokbel K; Mansel RE
Eur J Cancer; 2005 Jul; 41(11):1628-36. PubMed ID: 15951164
[TBL] [Abstract][Full Text] [Related]
52. Recent advances in neurobiology of Tuberous Sclerosis Complex.
Napolioni V; Moavero R; Curatolo P
Brain Dev; 2009 Feb; 31(2):104-13. PubMed ID: 19028034
[TBL] [Abstract][Full Text] [Related]
53. Association of TSC1/hamartin, 14-3-3sigma, and p27 expression with tumor outcomes in patients with pTa/pT1 urothelial bladder carcinoma.
Mhawech-Fauceglia P; Alvarez V; Fischer G; Beck A; Herrmann FR
Am J Clin Pathol; 2008 Jun; 129(6):918-23. PubMed ID: 18480009
[TBL] [Abstract][Full Text] [Related]
54. The mTOR inhibitor rapamycin significantly improves facial angiofibroma lesions in a patient with tuberous sclerosis.
Hofbauer GF; Marcollo-Pini A; Corsenca A; Kistler AD; French LE; Wüthrich RP; Serra AL
Br J Dermatol; 2008 Aug; 159(2):473-5. PubMed ID: 18547304
[TBL] [Abstract][Full Text] [Related]
55. Mutation detection in tumor suppressor genes using archival tissue specimens.
Astrinidis A; Henske EP
Methods Mol Med; 2006; 126():185-96. PubMed ID: 16930013
[TBL] [Abstract][Full Text] [Related]
56. The tuberous sclerosis complex: balancing proliferation and survival.
Tomasoni R; Mondino A
Biochem Soc Trans; 2011 Apr; 39(2):466-71. PubMed ID: 21428921
[TBL] [Abstract][Full Text] [Related]
57. Novel mutations in 21 patients with tuberous sclerosis complex and variation of tandem splice-acceptor sites in TSC1 exon 14.
Sasongko TH; Wataya-Kaneda M; Koterazawa K; Gunadi ; Yusoff S; Harahap IS; Lee MJ; Matsuo M; Nishio H
Kobe J Med Sci; 2008 May; 54(1):E73-81. PubMed ID: 18772611
[TBL] [Abstract][Full Text] [Related]
58. Large deletion at the TSC1 locus in a family with tuberous sclerosis complex.
Nellist M; Sancak O; Goedbloed MA; van Veghel-Plandsoen M; Maat-Kievit A; Lindhout D; Eussen BH; de Klein A; Halley DJ; van den Ouweland AM
Genet Test; 2005; 9(3):226-30. PubMed ID: 16225402
[TBL] [Abstract][Full Text] [Related]
59. Inactivation of the cyclin-dependent kinase inhibitor p27 upon loss of the tuberous sclerosis complex gene-2.
Soucek T; Yeung RS; Hengstschläger M
Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15653-8. PubMed ID: 9861025
[TBL] [Abstract][Full Text] [Related]
60. The tuberous sclerosis complex genes in tumor development.
Mak BC; Yeung RS
Cancer Invest; 2004; 22(4):588-603. PubMed ID: 15565817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
